• レポートコード:GIR-107A12186 • 出版社/出版日:GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、101ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、規制物質のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。規制物質の種類別市場規模(オピオイド、覚醒剤、抑制剤、マリファナ、その他)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・規制物質の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Johnson & Johnson、Pfizer、Siegfried AG、GlaxoSmithKline、Teva Pharmaceuticals、Mylan、Takeda Pharmaceutical、Sun Pharmaceutical、Daiichi Sankyo、Akorn Inc、Tilray、Medical Marijuana, Inc、Consort Medical、Purdue Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:オピオイド、覚醒剤、抑制剤、マリファナ、その他 ・用途別分析2016年-2026年:病院薬局、小売薬局、オンライン薬局 ・規制物質の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・規制物質のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・規制物質のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・規制物質の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・規制物質の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Controlled Substances market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Controlled Substances size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Controlled Substances market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Controlled Substances market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Opioids
Stimulants
Depressants
Marijuana
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Mylan
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Controlled Substances
1.2 Classification of Controlled Substances by Type
1.2.1 Overview: Global Controlled Substances Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Controlled Substances Revenue Market Share by Type in 2020
1.2.3 Opioids
1.2.4 Stimulants
1.2.5 Depressants
1.2.6 Marijuana
1.2.7 Others
1.3 Global Controlled Substances Market by Application
1.3.1 Overview: Global Controlled Substances Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Controlled Substances Market Size & Forecast
1.5 Global Controlled Substances Market Size and Forecast by Region
1.5.1 Global Controlled Substances Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Controlled Substances Market Size by Region, (2016-2021)
1.5.3 North America Controlled Substances Market Size and Prospect (2016-2026)
1.5.4 Europe Controlled Substances Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Controlled Substances Market Size and Prospect (2016-2026)
1.5.6 South America Controlled Substances Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Controlled Substances Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Controlled Substances Market Drivers
1.6.2 Controlled Substances Market Restraints
1.6.3 Controlled Substances Trends Analysis
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Controlled Substances Product and Solutions
2.1.4 Johnson & Johnson Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Controlled Substances Product and Solutions
2.2.4 Pfizer Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Siegfried AG
2.3.1 Siegfried AG Details
2.3.2 Siegfried AG Major Business
2.3.3 Siegfried AG Controlled Substances Product and Solutions
2.3.4 Siegfried AG Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Siegfried AG Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Controlled Substances Product and Solutions
2.4.4 GlaxoSmithKline Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Teva Pharmaceuticals
2.5.1 Teva Pharmaceuticals Details
2.5.2 Teva Pharmaceuticals Major Business
2.5.3 Teva Pharmaceuticals Controlled Substances Product and Solutions
2.5.4 Teva Pharmaceuticals Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Controlled Substances Product and Solutions
2.6.4 Mylan Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Mylan Recent Developments and Future Plans
2.7 Takeda Pharmaceutical
2.7.1 Takeda Pharmaceutical Details
2.7.2 Takeda Pharmaceutical Major Business
2.7.3 Takeda Pharmaceutical Controlled Substances Product and Solutions
2.7.4 Takeda Pharmaceutical Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Takeda Pharmaceutical Recent Developments and Future Plans
2.8 Sun Pharmaceutical
2.8.1 Sun Pharmaceutical Details
2.8.2 Sun Pharmaceutical Major Business
2.8.3 Sun Pharmaceutical Controlled Substances Product and Solutions
2.8.4 Sun Pharmaceutical Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sun Pharmaceutical Recent Developments and Future Plans
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business
2.9.3 Daiichi Sankyo Controlled Substances Product and Solutions
2.9.4 Daiichi Sankyo Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Daiichi Sankyo Recent Developments and Future Plans
2.10 Akorn Inc
2.10.1 Akorn Inc Details
2.10.2 Akorn Inc Major Business
2.10.3 Akorn Inc Controlled Substances Product and Solutions
2.10.4 Akorn Inc Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Akorn Inc Recent Developments and Future Plans
2.11 Tilray
2.11.1 Tilray Details
2.11.2 Tilray Major Business
2.11.3 Tilray Controlled Substances Product and Solutions
2.11.4 Tilray Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Tilray Recent Developments and Future Plans
2.12 Medical Marijuana, Inc
2.12.1 Medical Marijuana, Inc Details
2.12.2 Medical Marijuana, Inc Major Business
2.12.3 Medical Marijuana, Inc Controlled Substances Product and Solutions
2.12.4 Medical Marijuana, Inc Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Medical Marijuana, Inc Recent Developments and Future Plans
2.13 Consort Medical
2.13.1 Consort Medical Details
2.13.2 Consort Medical Major Business
2.13.3 Consort Medical Controlled Substances Product and Solutions
2.13.4 Consort Medical Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Consort Medical Recent Developments and Future Plans
2.14 Purdue Pharma
2.14.1 Purdue Pharma Details
2.14.2 Purdue Pharma Major Business
2.14.3 Purdue Pharma Controlled Substances Product and Solutions
2.14.4 Purdue Pharma Controlled Substances Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Purdue Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Controlled Substances Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Controlled Substances Players Market Share
3.2.2 Top 10 Controlled Substances Players Market Share
3.2.3 Market Competition Trend
3.3 Controlled Substances Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Controlled Substances Revenue and Market Share by Type (2016-2021)
4.2 Global Controlled Substances Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Controlled Substances Revenue Market Share by Application (2016-2021)
5.2 Controlled Substances Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Controlled Substances Revenue by Type (2016-2026)
6.2 North America Controlled Substances Revenue by Application (2016-2026)
6.3 North America Controlled Substances Market Size by Country
6.3.1 North America Controlled Substances Revenue by Country (2016-2026)
6.3.2 United States Controlled Substances Market Size and Forecast (2016-2026)
6.3.3 Canada Controlled Substances Market Size and Forecast (2016-2026)
6.3.4 Mexico Controlled Substances Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Controlled Substances Revenue by Type (2016-2026)
7.2 Europe Controlled Substances Revenue by Application (2016-2026)
7.3 Europe Controlled Substances Market Size by Country
7.3.1 Europe Controlled Substances Revenue by Country (2016-2026)
7.3.2 Germany Controlled Substances Market Size and Forecast (2016-2026)
7.3.3 France Controlled Substances Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Controlled Substances Market Size and Forecast (2016-2026)
7.3.5 Russia Controlled Substances Market Size and Forecast (2016-2026)
7.3.6 Italy Controlled Substances Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Controlled Substances Revenue by Type (2016-2026)
8.2 Asia-Pacific Controlled Substances Revenue by Application (2016-2026)
8.3 Asia-Pacific Controlled Substances Market Size by Region
8.3.1 Asia-Pacific Controlled Substances Revenue by Region (2016-2026)
8.3.2 China Controlled Substances Market Size and Forecast (2016-2026)
8.3.3 Japan Controlled Substances Market Size and Forecast (2016-2026)
8.3.4 South Korea Controlled Substances Market Size and Forecast (2016-2026)
8.3.5 India Controlled Substances Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Controlled Substances Market Size and Forecast (2016-2026)
8.3.7 Australia Controlled Substances Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Controlled Substances Revenue by Type (2016-2026)
9.2 South America Controlled Substances Revenue by Application (2016-2026)
9.3 South America Controlled Substances Market Size by Country
9.3.1 South America Controlled Substances Revenue by Country (2016-2026)
9.3.2 Brazil Controlled Substances Market Size and Forecast (2016-2026)
9.3.3 Argentina Controlled Substances Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Controlled Substances Revenue by Type (2016-2026)
10.2 Middle East & Africa Controlled Substances Revenue by Application (2016-2026)
10.3 Middle East & Africa Controlled Substances Market Size by Country
10.3.1 Middle East & Africa Controlled Substances Revenue by Country (2016-2026)
10.3.2 Turkey Controlled Substances Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Controlled Substances Market Size and Forecast (2016-2026)
10.3.4 UAE Controlled Substances Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Controlled Substances Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Controlled Substances Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Controlled Substances Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Controlled Substances Revenue (USD Million) by Region (2016-2021)
Table 5. Global Controlled Substances Revenue Market Share by Region (2021-2026)
Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 7. Johnson & Johnson Major Business
Table 8. Johnson & Johnson Controlled Substances Product and Solutions
Table 9. Johnson & Johnson Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Controlled Substances Product and Solutions
Table 13. Pfizer Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Siegfried AG Corporate Information, Head Office, and Major Competitors
Table 15. Siegfried AG Major Business
Table 16. Siegfried AG Controlled Substances Product and Solutions
Table 17. Siegfried AG Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Controlled Substances Product and Solutions
Table 21. GlaxoSmithKline Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Teva Pharmaceuticals Major Business
Table 24. Teva Pharmaceuticals Controlled Substances Product and Solutions
Table 25. Teva Pharmaceuticals Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Mylan Corporate Information, Head Office, and Major Competitors
Table 27. Mylan Major Business
Table 28. Mylan Controlled Substances Product and Solutions
Table 29. Mylan Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 31. Takeda Pharmaceutical Major Business
Table 32. Takeda Pharmaceutical Controlled Substances Product and Solutions
Table 33. Takeda Pharmaceutical Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Sun Pharmaceutical Major Business
Table 36. Sun Pharmaceutical Controlled Substances Product and Solutions
Table 37. Sun Pharmaceutical Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 39. Daiichi Sankyo Major Business
Table 40. Daiichi Sankyo Controlled Substances Product and Solutions
Table 41. Daiichi Sankyo Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Akorn Inc Corporate Information, Head Office, and Major Competitors
Table 43. Akorn Inc Major Business
Table 44. Akorn Inc Controlled Substances Product and Solutions
Table 45. Akorn Inc Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Tilray Corporate Information, Head Office, and Major Competitors
Table 47. Tilray Major Business
Table 48. Tilray Controlled Substances Product and Solutions
Table 49. Tilray Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Medical Marijuana, Inc Corporate Information, Head Office, and Major Competitors
Table 51. Medical Marijuana, Inc Major Business
Table 52. Medical Marijuana, Inc Controlled Substances Product and Solutions
Table 53. Medical Marijuana, Inc Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Consort Medical Corporate Information, Head Office, and Major Competitors
Table 55. Consort Medical Major Business
Table 56. Consort Medical Controlled Substances Product and Solutions
Table 57. Consort Medical Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Purdue Pharma Corporate Information, Head Office, and Major Competitors
Table 59. Purdue Pharma Major Business
Table 60. Purdue Pharma Controlled Substances Product and Solutions
Table 61. Purdue Pharma Controlled Substances Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Controlled Substances Revenue (USD Million) by Players (2019-2021)
Table 63. Global Controlled Substances Revenue Share by Players (2019-2021)
Table 64. Breakdown of Controlled Substances by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Controlled Substances Players Head Office, Products and Services Provided
Table 66. Controlled Substances Mergers & Acquisitions in the Past Five Years
Table 67. Controlled Substances New Entrants and Expansion Plans
Table 68. Global Controlled Substances Revenue (USD Million) by Type (2016-2021)
Table 69. Global Controlled Substances Revenue Share by Type (2016-2021)
Table 70. Global Controlled Substances Revenue Forecast by Type (2021-2026)
Table 71. Global Controlled Substances Revenue by Application (2016-2021)
Table 72. Global Controlled Substances Revenue Forecast by Application (2021-2026)
Table 73. North America Controlled Substances Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Controlled Substances Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Controlled Substances Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Controlled Substances Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Controlled Substances Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Controlled Substances Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Controlled Substances Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Controlled Substances Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Controlled Substances Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Controlled Substances Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Controlled Substances Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Controlled Substances Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Controlled Substances Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Controlled Substances Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Controlled Substances Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Controlled Substances Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Controlled Substances Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Controlled Substances Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Controlled Substances Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Controlled Substances Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Controlled Substances Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Controlled Substances Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Controlled Substances Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Controlled Substances Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Controlled Substances Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Controlled Substances Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Controlled Substances Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Controlled Substances Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Controlled Substances Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Controlled Substances Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Controlled Substances Picture
Figure 2. Global Controlled Substances Revenue Market Share by Type in 2020
Figure 3. Opioids
Figure 4. Stimulants
Figure 5. Depressants
Figure 6. Marijuana
Figure 7. Others
Figure 8. Controlled Substances Revenue Market Share by Application in 2020
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Controlled Substances Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Controlled Substances Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Controlled Substances Revenue Market Share by Region (2016-2026)
Figure 15. Global Controlled Substances Revenue Market Share by Region in 2020
Figure 16. North America Controlled Substances Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Controlled Substances Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Controlled Substances Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Controlled Substances Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Controlled Substances Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Controlled Substances Market Drivers
Figure 22. Controlled Substances Market Restraints
Figure 23. Controlled Substances Market Trends
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. Siegfried AG Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Recent Developments and Future Plans
Figure 28. Teva Pharmaceuticals Recent Developments and Future Plans
Figure 29. Mylan Recent Developments and Future Plans
Figure 30. Takeda Pharmaceutical Recent Developments and Future Plans
Figure 31. Sun Pharmaceutical Recent Developments and Future Plans
Figure 32. Daiichi Sankyo Recent Developments and Future Plans
Figure 33. Akorn Inc Recent Developments and Future Plans
Figure 34. Tilray Recent Developments and Future Plans
Figure 35. Medical Marijuana, Inc Recent Developments and Future Plans
Figure 36. Consort Medical Recent Developments and Future Plans
Figure 37. Purdue Pharma Recent Developments and Future Plans
Figure 38. Global Controlled Substances Revenue Share by Players in 2020
Figure 39. Controlled Substances Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Controlled Substances Revenue Market Share in 2020
Figure 41. Global Top 10 Players Controlled Substances Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Controlled Substances Revenue Share by Type in 2020
Figure 44. Global Controlled Substances Market Share Forecast by Type (2021-2026)
Figure 45. Global Controlled Substances Revenue Share by Application in 2020
Figure 46. Global Controlled Substances Market Share Forecast by Application (2021-2026)
Figure 47. North America Controlled Substances Sales Market Share by Type (2016-2026)
Figure 48. North America Controlled Substances Sales Market Share by Application (2016-2026)
Figure 49. North America Controlled Substances Revenue Market Share by Country (2016-2026)
Figure 50. United States Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Controlled Substances Sales Market Share by Type (2016-2026)
Figure 54. Europe Controlled Substances Sales Market Share by Application (2016-2026)
Figure 55. Europe Controlled Substances Revenue Market Share by Country (2016-2026)
Figure 56. Germany Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Controlled Substances Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Controlled Substances Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Controlled Substances Revenue Market Share by Region (2016-2026)
Figure 64. China Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Controlled Substances Sales Market Share by Type (2016-2026)
Figure 71. South America Controlled Substances Sales Market Share by Application (2016-2026)
Figure 72. South America Controlled Substances Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Controlled Substances Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Controlled Substances Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Controlled Substances Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Controlled Substances Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source